Cargando…

Association of glioma CD44 expression with glial dynamics in the tumour microenvironment and patient prognosis

Because of the heterogeneity of lower-grade gliomas (LGGs), patients show various survival outcomes that are not reliably predicted by histological classification. The tumour microenvironment (TME) contributes to the initiation and progression of brain LGGs. Identifying potential prognostic markers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Zhanxin, Wang, Yaqing, Liang, Jiaqi, Gao, Shaowei, Cai, Xiaoying, Yu, Yu, Qi, Zhihui, Li, Jing, Xie, Yubin, Wang, Zhongxing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Research Network of Computational and Structural Biotechnology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508470/ https://www.ncbi.nlm.nih.gov/pubmed/36187921 http://dx.doi.org/10.1016/j.csbj.2022.09.003

Ejemplares similares

Investigating the Causal Relationship Between Physical Activity and Chronic Back Pain: A Bidirectional Two-Sample Mendelian Randomization Study
por: Gao, Shaowei, et al.
Publicado: (2021)

Central venous pressure monitoring and mortality: What was neglected?
por: Gao, Shaowei, et al.
Publicado: (2020)

Elevated CD44 expression predicts poor prognosis in patients with low-grade glioma
por: Dong, Qiang, et al.
Publicado: (2019)

ATRX regulates glial identity and the tumor microenvironment in IDH-mutant glioma
por: Babikir, Husam, et al.
Publicado: (2021)

Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma
por: Cai, Jiayang, et al.
Publicado: (2022)

CD44-Mediated Poor Prognosis in Glioma Is Associated With M2-Polarization of Tumor-Associated Macrophages and Immunosuppression
por: Xiao, Yong, et al.
Publicado: (2022)

Comment on “Expression of CD44 and the survival in glioma: a meta-analysis”
por: Hou, Chongxian, et al.
Publicado: (2020)

Characteristics and clinical subtypes of cancer patients in the intensive care unit: a retrospective observational study for two large databases
por: Gao, Shaowei, et al.
Publicado: (2021)

Expression of CD44 and the survival in glioma: a meta-analysis
por: Wu, Gang, et al.
Publicado: (2020)

CD44 expressed by myeloid cells promotes glioma invasion
por: Ivanova, Ekaterina L., et al.
Publicado: (2022)

GALNT2 sustains glioma stem cells by promoting CD44 expression
por: Liu, Yingying, et al.
Publicado: (2023)

Immune‐related matrisomes are potential biomarkers to predict the prognosis and immune microenvironment of glioma patients
por: Yu, Hao, et al.
Publicado: (2022)

Mutational profiling of low‐grade gliomas identifies prognosis and immunotherapy‐related biomarkers and tumour immune microenvironment characteristics
por: Lin, Wen‐wen, et al.
Publicado: (2021)

Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma
por: Zhang, Yulian, et al.
Publicado: (2022)

Identification of glioma-associated antigen MUC 2-63 as CD44.
por: Romeijn, P., et al.
Publicado: (1994)

A Focal Adhesion-Related Gene Signature Predicts Prognosis in Glioma and Correlates With Radiation Response and Immune Microenvironment
por: Li, Haonan, et al.
Publicado: (2021)

Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer
por: Wu, Cheng-Lin, et al.
Publicado: (2015)

CD74 Correlated With Malignancies and Immune Microenvironment in Gliomas
por: Xu, Shengchao, et al.
Publicado: (2021)

Functional analysis of CD44 variants and xCT in canine tumours
por: Tanabe, Atsushi, et al.
Publicado: (2020)

Correlation analysis of expression and prognosis of TTF-1 and CD44v6 in undifferentiated lung carcinoma
por: Wu, Yudong, et al.
Publicado: (2019)

CD44 Variant Isoform Expression and Breast Cancer Prognosis
por: Tokue, Yutaka, et al.
Publicado: (1998)

Predictive Value of CD44 for Prognosis in Patients with Breast Cancer
por: Roosta, Yousef, et al.
Publicado: (2020)

CD44(+)/CD24(−) phenotype predicts a poor prognosis in triple-negative breast cancer
por: Wang, Hui, et al.
Publicado: (2017)

CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach
por: Cao, Xueyuan, et al.
Publicado: (2014)

Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression Level
por: Klank, Rebecca L., et al.
Publicado: (2017)

Galangin inhibits epithelial-mesenchymal transition and angiogenesis by downregulating CD44 in glioma
por: Chen, Daliang, et al.
Publicado: (2019)

CD44 promotes the migration of bone marrow-derived mesenchymal stem cells toward glioma
por: YIN, QIANG, et al.
Publicado: (2016)

Hallmarks of the Tumour Microenvironment of Gliomas and Its Interaction with Emerging Immunotherapy Modalities
por: Linares, Christian A., et al.
Publicado: (2023)

Bioinformatic Profiling of Prognosis-Related Genes in Malignant Glioma Microenvironment
por: Li, Yong, et al.
Publicado: (2020)

Identification of an ATP metabolism‐related signature associated with prognosis and immune microenvironment in gliomas
por: Huang, Ruoyu, et al.
Publicado: (2020)

EVA1B to Evaluate the Tumor Immune Microenvironment and Clinical Prognosis in Glioma
por: Qu, Shanqiang, et al.
Publicado: (2021)

miR-200b inhibits CD133(+) glioma cells by targeting the AKT pathway
por: Liu, Aiqun, et al.
Publicado: (2017)

Prognosis and clinical features analysis of EMT-related signature and tumor Immune microenvironment in glioma
por: Xiao, Zheng, et al.
Publicado: (2023)

Differential CD44 expression patterns in primary brain tumours and brain metastases.
por: Li, H., et al.
Publicado: (1995)

High Expression of CD44 Predicts a Poor Prognosis in Glioblastomas
por: Si, Daolin, et al.
Publicado: (2020)

A Novel S100 Family-Based Signature Associated with Prognosis and Immune Microenvironment in Glioma
por: Hu, Yifang, et al.
Publicado: (2021)

The Predictive Value of Monocytes in Immune Microenvironment and Prognosis of Glioma Patients Based on Machine Learning
por: Zhang, Nan, et al.
Publicado: (2021)

Tumour stem cell markers CD133 and CD44 are useful prognostic factors after surgical resection of pancreatic neuroendocrine tumours
por: Sun, Zhonghai, et al.
Publicado: (2020)

Expression of Monocarboxylate Transporters 1, 2, and 4 in Human Tumours and Their Association with CD147 and CD44
por: Pinheiro, Céline, et al.
Publicado: (2010)

Alarm Signal S100-Related Signature Is Correlated with Tumor Microenvironment and Predicts Prognosis in Glioma
por: Wang, Lin-jian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6vtah0hfnltin8a1poirl2j5m2